In colorectal tumors, immunohistochemical analyses showed a high expression of MCT1 and a low level of GLUT1 expression in CAFs, while cancer cells exhibited strong expression of GLUT1, suggesting that CAFs take up tumor cell–derived lactate (20). The gene discussed is SLC2A1; the disease is cancer.